Johannes Schlondorff, MD

Renal Electrolyte and Hypertension
Accepting new patients
Sees patients age 18 and up
Penn Renal Electrolyte and Hypertension University City
Make an appointmentCall 800-789-7366
Penn Medicine Provider

About me

  • Associate Professor of Clinical Medicine (Renal-Electrolyte and Hypertension)

My education and training

  • Medical School: NewYork-Presbyterian / Weill Cornell Medical Center
  • Residency: NewYork-Presbyterian/Columbia University Medical Center
  • Fellowship: Massachusetts General Hospital/Brigham and Women’s Hospital

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Schlondorff is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Sula Karreci E, Jacas S, Donovan O, Pintye D, Wiley N, Zsengeller ZK, Schlondorff J, Alper SL, Friedman DJ, Pollak MR. Differing sensitivities to angiotensin converting enzyme inhibition of kidney disease mediated by APOL1 high-risk variants G1 and G2 , Kidney Int, 106(6): 2024,1072-1085

Madhavan SM, Schlöndorff JS. Variant upon variant: kidney-disease risk associated with APOL1 G2 genetic variants is abrogated by the APOL1 p.N264K variant , Kidney Int, 106(3): 2024,345-348

Thomas CP, Daloul R, Lentine KL, Gohh R, Anand PM, Rasouly HM, Sharfuddin AA, Schlondorff JS, Rodig NM, Freese ME, Garg N, Lee BK, Caliskan Y. Genetic evaluation of living kidney donor candidates: A review and recommendations for best practices , Am J Transplant, 23(5): 2023,597-607

Brown BJ, Boekell KL, Stotter BR, Talbot BE, Schlondorff JS. Gain-of-function, focal segmental glomerulosclerosis Trpc6 mutation minimally affects susceptibility to renal injury in several mouse models , PLoS One, 17: 2022,e0272313

Boekell KL, Brown BJ, Talbot BE, Schlondorff JS. Trpc6 gain-of-function disease mutation enhances phosphatidylserine exposure in murine platelets , PLoS One, 17: 2022,e0270431

Sun H, Perez-Gill C, Schlöndorff JS, Subramanian B, Pollak MR. Dysregulated Dynein-Mediated Trafficking of Nephrin Causes INF2-related Podocytopathy , J Am Soc Nephrol, 32(2): 2021,307-322

Schlöndorff JS. My, oh, MYO9A! Just how complex can regulation of the podocyte actin cytoskeleton get? , Kidney Int, 99(5): 2021,1065-1067

Pandit A, Schlondorff J. Posaconazole-Induced Apparent Mineralocorticoid Excess , Kidney Int Rep, 5(12): 2020,2379-2382

Feng D, Kumar M, Muntel J, Gurley SB, Birrane G, Stillman IE, Ding L, Wang M, Ahmed S, Schlondorff J, Alper SL, Ferrante T, Marquez SL, Ng CF, Novak R, Ingber DE, Steen H, Pollak MR. Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis , J Am Soc Nephrol, 31(7): 2020,1479-1495

Stotter BR, Talbot BE, Capen DE, Artelt N, Zeng J, Matsumoto Y, Endlich N, Cummings RD, Schlondorff JS. Cosmc-dependent mucin-type O-linked glycosylation is essential for podocyte function , Am J Physiol Renal Physiol, 318(2): 2020,F518-F530